News • Millifluidic nanogenerator
Blood-powered lab-on-a-chip to enhance disease monitoring
Researchers are proposing a new device that uses blood to generate electricity and measure its conductivity, opening doors to medical care in any location.
Testing devices
News • Integration of microanalysis chips
Establishing microfluidic control technology for blood testing devices
A research group established a microfluidic control technology that can be applied to small blood testing devices and consequently developed a novel integrated immunoassay device.
News • Urine-based diagnostics
New prostate cancer test to help avoid unnecessary biopsies
US researchers have developed and validated a new urine-based test for prostate cancer, which was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection.
Article • Proof-of-concept study
First test for the early detection of head and neck cancer being developed
Most head and neck tumours are discovered in late due in part to the fact that there is no established method for early detection. To close this gap, a team at oncgnostics, a biotechnology company based in Jena, Germany, is participating in a study which aims to develop an early detection test.
News • Saliva test device
Breast cancer screening: Biosensor could offer alternative to diagnostic imaging
A newly-developed biosensor could be an alterative to MRI and mammography for breast cancer screening. The handheld device uses saliva on test strips to determine whether cancer is present.
Article • QC at AACC 2023
New risk-based quality control assessment for clinical labs
Juggling the cost of quality control (QC) resources versus the risk of testing error is a balancing act no clinical laboratory manager enjoys. It is an inexact process, itself prone to error, which can impact the operations of hospital labs and independent clinical testing companies. In the current resource-constrained healthcare environment, there is pressure to improve the cost effectiveness of…
News • Sexual health pilot project
Vending machines offer convenient STI testing
Vending machines dispensing self-test kits for sexually transmitted infections (STIs) have proven to be an effective and widely accepted means of reaching individuals who rarely or never get tested.
Sponsored • Accurate, efficient, and versatile X-ray meter
Meet Mako: the latest in X-ray QA testing
RTI presents its latest advancement in X-ray Quality Assurance and testing. Centered around efficiency, Mako provides the ultimate no-fuss experience, simple setup in all X-ray applications, and fully wireless capability.
Article • Addressing an unmet need
MCED: a simple test for widespread early detection of cancer
Academic labs and biotech firms pioneer multi-cancer early detection with emerging technologies. Screening for multiple cancers with a simple blood or urinary draw could be a game-changer. Two research teams in particular have advanced the field.
News • Noninvasive fetal screening
Blood test to identify genetic diseases in unborn babies
A research team from Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.
News • Based on image-based flow cytometry
Rapid test to predict severe Covid-19 infections
Researchers have developed a method for assessing the number and structure of aggregated blood platelets (or thrombocytes) that can potentially help quantify the risk of a severe Covid-19 infection. As a result, they have identified a predictive biomarker for the seriousness of a Covid-19 infection. This will allow physicians to adjust treatment at an early stage. The researchers used a method…
News • Using AI nanopores
New rapid testing method for Covid-19
Researchers from Osaka University present a novel technique to detect different coronavirus variants quickly, including fast-spreading strains present in human saliva.
News • Preparing for the next pandemic
New rapid electronic diagnostic test for infectious diseases
A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.
News • Spirometry distribution
The ‘silent scandal’ of missing lung tests across England
A new survey by The BMJ reveals shortages of vital diagnostic tests for respiratory conditions, such as COPD and asthma, across some of the most deprived areas of England.
Article • Cancer patients at risk
Blood test detects risk of neurotoxicity from CAR T-cell therapy
Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…
News • MCED for 50+ cancer types
Multi-cancer blood test shows real promise
A trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms.
News • Pre-eclampsia
Detecting high-risk pregnancy with heart attack test
About 5% of all women develop pre-eclampsia during pregnancy, which in severe cases can become life-threatening for mother and child. Using commercially available troponin tests, high-risk patients could be identified much earlier and more accurately than before.
News • Molecular test for bacteria response
New method rapidly reveals antibiotic resistance
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes.
News • Perilous PSA policy
Prostate cancer ‘test by request’ drives overdiagnosis, argue experts
Experts argue that shared decision policies between patients and their doctors have led to high rates of PSA testing and clear medical harm, with minimal benefit and inequity.
News • Accuracy gain
Bowel cancer: double testing for better detection
Scientists from the University of Edinburgh have found that the accuracy of detecting bowel cancer is increased to almost 100% by carrying out a common test twice rather than once.
Article • Confirming initial positive findings
First-tier rapid serology testing for Lyme disease
Lyme disease, the most common tick-transmitted bacterial infection in the world, is challenging to diagnose. Initial early-stage symptoms may include skin rash, fever, headache, fatigue, swollen lymph nodes, and/or body and joint aches. However, these symptoms are also associated with many other diseases and medical conditions.
Sponsored • Promising combination: AFP, AFP-L3, DCP and GALAD score
Enhanced early detection of liver cancer
Worldwide, about one million people are suffering from hepatocellular carcinoma (HCC). In Germany alone, there are 9,000 new patients each year, most of them men between 50 and 60 years. When liver cancer is detected early, the prognosis is excellent, says Professor Dr. Ali Canbay, Director of the Medical Clinic at the University Hospital/Knappschaftskrankenhaus Bochum. While, unfortunately,…
Article • Cervix, vulva and vagina
More certainty with methylation tests for early detection of cancer
A second-generation lab test for early detection of cervical cancer is the most recent addition to Oncgnostics’ portfolio. In particular, the company’s solution will help women in countries with limited cancer screening. Moreover, new research on the early detection of vulval and vaginal cancer might soon enable the development of tests for these cancers.
News • Rapid screening diagnostic
94% accuracy: new prostate cancer blood test beats PSA method
Researchers have developed a new blood test to detect prostate cancer which displays greater accuracy than the current prostate-specific antigen (PSA) method.
News • Neurodegeneration assessment
New blood test differentiates Alzheimer’s disease from other dementias
A new blood test that can track and follow the neurodegeneration in Alzheimer's disease - and exclude other dementias.
